✦ LIBER ✦

Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders

✍ Scribed by Nick C. Patel; M. Lynn Crismon; Alan Shafer; Anthony De Leon; Molly Lopez; Daniel C. Lane

Book ID: 105823630
Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 103 KB
Volume: 41
Category: Article
ISSN: 1433-9285
DOI: 10.1007/s00127-006-0036-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anxiety symptoms in schizophrenia spectr

Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history

✍ P. H. Lysaker; M. P. Salyers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Variations in responses to a symptom che

Variations in responses to a symptom check-list by age, sex, income, residence and ethnicity

✍ F. Engelsmann; H. B. M. Murphy; R. Prince; M. Leduc; H. Demers 📂 Article 📅 1972 🏛 Springer-Verlag 🌐 English ⚖ 656 KB

Quetiapine has equivalent efficacy and s

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms

✍ M. Riedel; N. Müller; M. Strassnig; I. Spellmann; R. R. Engel; R. Musil; S. Dehn 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

Safety and efficacy of long-acting injec

Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients

✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or

Responsiveness to Threat and Incentive i

Responsiveness to Threat and Incentive in Bipolar Disorder: Relations of the BIS/BAS Scales with Symptoms

✍ Björn Meyer; Sheri L. Johnson; Ray Winters 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 67 KB

Comments to the Editor on “Outcomes and

Comments to the Editor on “Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model”

📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB